Phase I DART
Faculty Members:
Patricia LoRusso, DO, Leader
Angela Davies, MD
Navid Hafez, MD, MPH
Joseph Kim, MD
Navid Hafez, MD, MPH
Joseph Kim, MD
Staff:
Mandy DeMerchant
Michael Lachowicz
Objectives:
- To develop new and improved cancer therapeutics.
- To maintain a portfolio of novel cancer therapeutics to service our cancer patient community
- To assist in the development, understanding, characterization, and approval of new drug therapies
- Strategically cultivate and nurture sponsored research activities
Research Meetings: Thursdays at 2pm in WWW 208
Operations Meeting: Tuesdays at 12pm
Tumor Board Meetings: 2nd Monday of the month at 4:30pm in Tumor Board Conference Room